Access cutting-edge intracerebral hemorrhage treatment through this clinical trial at a research site in Chandler. Study-provided care at no cost to qualified participants.
Access intracerebral hemorrhage specialists in Chandler at no cost
This study follows strict safety protocols and ethical guidelines
All study-related intracerebral hemorrhage treatment provided free
Primary Aim: To determine if apixaban is superior to aspirin for prevention of the composite outcome of any stroke (hemorrhagic or ischemic) or death from any cause in patients with recent ICH and atrial fibrillation (AF). Secondary Aim: To determine if apixaban, compared with aspirin, results in better functional outcomes as measured by the modified Rankin Scale.
Sponsor: Yale University
Check if you qualify for this intracerebral hemorrhage clinical trial in Chandler, AZ
If you're searching for intracerebral hemorrhage treatment options in Chandler, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Chandler research site is actively enrolling participants for this clinical trial. You'll receive care from experienced intracerebral hemorrhage specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.